This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhou, P. Articles by Seder, R. A. Search for Related Content PubMed PubMed Citation Articles by Zhou, P. Articles by Seder, R. A.

 Previous Article  |  Next Article 

Infect. Immun., Mar 1997, 936-942, Vol 65, No. 3
Copyright © 1997, American Society for Microbiology

Interleukin-12 modulates the protective immune response in SCID mice infected with Histoplasma capsulatum

P Zhou, MC Sieve, RP Tewari and RA Seder
Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.

Infection with Histoplasma capsulatum results in a subclinical infection in immunocompetent hosts due to an effective cellular immune response. By contrast, immunodeficient individuals can have a severe disseminated and potentially fatal disease. In a previous study, it was demonstrated that normal mice infected intravenously with H. capsulatum and treated with interleukin-12 (IL-12) at the time of infection were protected from a fatal outcome. In this study, we examined the immunomodulatory effects of IL-12 on disseminated histoplasmosis in immunodeficient SCID mice. SCID mice infected with H. capsulatum and treated with IL-12 showed an increase in survival and a reduction in the colony counts of H. capsulatum in internal organs at 14 days after infection. The protective effect of IL-12 was abrogated if animals were also treated with a neutralizing antibody to gamma interferon (IFN- gamma). IL-12 treatment also resulted in an increase in mRNA expression and protein production for IFN-gamma, tumor necrosis factor alpha (TNF- alpha), and nitric oxide from spleen cells. When IL-12 was combined with amphotericin B (AmB) treatment, there was a significant increase in survival compared with either modality alone. Moreover, combined treatment resulted in an increase in both IFN-gamma and TNF-alpha production, as well as in a substantial reduction in H. capsulatum burden at 35 and 90 days postinfection. This study demonstrates that IL- 12 modulates the protective immune response to histoplasmosis in SCID mice and also suggests that IL-12 in combination with AmB may be useful as a treatment for H. capsulatum in immunodeficient hosts.

This article has been cited by other articles:

• de Bastos Ascenco Soares, R., Gomez, F. J., de Almeida Soares, C. M., Deepe, G. S. Jr. (2008). Vaccination with Heat Shock Protein 60 Induces a Protective Immune Response against Experimental Paracoccidioides brasiliensis Pulmonary Infection. Infect. Immun. 76: 4214-4221 [Abstract] [Full Text]  
• Newman, S. L., Gootee, L., Hilty, J., Morris, R. E. (2006). Human Macrophages Do Not Require Phagosome Acidification to Mediate Fungistatic/Fungicidal Activity against Histoplasma capsulatum. J. Immunol. 176: 1806-1813 [Abstract] [Full Text]  
• Zhou, P., Freidag, B. L., Caldwell, C. C., Seder, R. A. (2001). Perforin Is Required for Primary Immunity to Histoplasma capsulatum. J. Immunol. 166: 1968-1974 [Abstract] [Full Text]  
• Connolly, P., Wheat, L. J., Schnizlein-Bick, C., Durkin, M., Kohler, S., Smedema, M., Goldberg, J., Brizendine, E., Loebenberg, D. (2000). Comparison of a New Triazole, Posaconazole, with Itraconazole and Amphotericin B for Treatment of Histoplasmosis following Pulmonary Challenge in Immunocompromised Mice. Antimicrob. Agents Chemother. 44: 2604-2608 [Abstract] [Full Text]  
• Murray, H. W., Delph-Etienne, S. (2000). Roles of Endogenous Gamma Interferon and Macrophage Microbicidal Mechanisms in Host Response to Chemotherapy in Experimental Visceral Leishmaniasis. Infect. Immun. 68: 288-293 [Abstract] [Full Text]  
• Mohan, K., Sam, H., Stevenson, M. M. (1999). Therapy with a Combination of Low Doses of Interleukin 12 and Chloroquine Completely Cures Blood-Stage Malaria, Prevents Severe Anemia, and Induces Immunity to Reinfection. Infect. Immun. 67: 513-519 [Abstract] [Full Text]  
• Zhou, P., Seder, R. A. (1998). CD40 Ligand Is Not Essential for Induction of Type 1 Cytokine Responses or Protective Immunity after Primary or Secondary Infection With Histoplasma capsulatum. J. Exp. Med. 187: 1315-1324 [Abstract] [Full Text]  
• Zhou, P., Miller, G., Seder, R. A. (1998). Factors Involved in Regulating Primary and Secondary Immunity to Infection with Histoplasma capsulatum: TNF-{alpha} Plays a Critical Role in Maintaining Secondary Immunity in the Absence of IFN-{gamma}. J. Immunol. 160: 1359-1368 [Abstract] [Full Text]